SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Qualified Opinion who wrote (3426)10/22/2002 12:27:31 AM
From: biostruggle  Read Replies (2) of 10345
 
Elan has to maintain collateral equal to QSPE even though due in 2004 and 2005. That is where tie up of cash comes from. The original QSPE are short 450 million, so Elan has to put up more cash in kitty or other investments. Elan has 1 billion in cash in 4 th q. A lot is tied up.
450 million supporting QSPE
250-300 million needed for operations.
Assumes no operating losses in 2003 and 2004

Only leaves 250-300 million left for 1.25 billion liabilities next year. So they need at least 1 billion in additional asset sales. Shorts do not believe Elan can pull it off.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext